Shahzad, Muhammad H.
Rayes, Roni F.
Cools-Lartigue, Jonathan
Spicer, Jonathan D.
Article History
Accepted: 13 October 2025
First Online: 12 November 2025
Competing interests
: J.D.S. has received speaker fees/honoraria/consulting fees from Merck, AstraZeneca, BMS, Roche, Novartis, Amgen, Regeneron, Daiichi-Sankyo, Eisai, PeerView, OncLive and Medscape; and grants from AstraZeneca, BMS, Merck, Roche, CLS Therapeutics and Protalix Biotherapeutics. All other authors have no competing interests to declare.